Nordic pharma market-access intelligence
A platform for understanding Swedish and Nordic pharmaceutical market access — HTA decisions, availability, and uptake, drawn together into a single view of how medicines reach patients.
Where centrally authorised substances stand in the Swedish access funnel.
How medicine use in Sweden has changed over time, and which substances reach the most people.